International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas

T Ohtsuka, C Fernandez-del Castillo, T Furukawa… - Pancreatology, 2023 - Elsevier
This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

[HTML][HTML] Artificial intelligence and early detection of pancreatic cancer: 2020 summative review

B Kenner, ST Chari, D Kelsen, DS Klimstra, SJ Pandol… - Pancreas, 2021 - journals.lww.com
Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis
and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly …

[HTML][HTML] Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals

KA Overbeek, MG Goggins, M Dbouk, IJM Levink… - Gastroenterology, 2022 - Elsevier
Background & Aims To successfully implement imaging-based pancreatic cancer (PC)
surveillance, understanding the timeline and morphologic features of neoplastic progression …

Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: A recursive partitioning analysis

A Facciorusso, B Kovacevic, D Yang, F Vilas-Boas… - …, 2022 - thieme-connect.com
Background and study aims Endoscopic ultrasound-guided through-the-needle biopsy
(TTNB) of pancreatic cystic lesions (PCLs) is associated with a non-negligible risk for …

Surveillance for presumed BD-IPMN of the pancreas: stability, size, and age identify targets for discontinuation

G Marchegiani, T Pollini, A Burelli, Y Han, HS Jung… - Gastroenterology, 2023 - Elsevier
Background & Aims Currently, most patients with branch duct intraductal papillary mucinous
neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with …

CT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas

J Chakraborty, A Midya, L Gazit, M Attiyeh… - Medical …, 2018 - Wiley Online Library
Purpose Intraductal papillary mucinous neoplasms (IPMN s) are radiographically visible
precursor lesions of pancreatic cancer. Despite standard criteria for assessing risk, only 18 …

Extracellular vesicle analysis allows for identification of invasive IPMN

KS Yang, D Ciprani, A O'Shea, AS Liss, R Yang… - Gastroenterology, 2021 - Elsevier
Background and Aims Advances in cross-sectional imaging have resulted in increased
detection of intraductal papillary mucinous neoplasms (IPMNs), and their management …

Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN …

S Hirono, Y Shimizu, T Ohtsuka, T Kin, K Hara… - Journal of …, 2020 - Springer
Background Although there are numerous reports focusing on surgical indication for
intraductal papillary mucinous neoplasm (IPMN), the recurrence patterns following surgery …

Risk of the watch-and-wait concept in surgical treatment of intraductal papillary mucinous neoplasm

C Tjaden, M Sandini, AL Mihaljevic, J Kaiser… - JAMA …, 2021 - jamanetwork.com
Importance The natural history of intraductal papillary mucinous neoplasms (IPMNs)
remains uncertain. The inconsistencies among published guidelines preclude accurate …

[HTML][HTML] Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas

S Hirono, H Yamaue - Surgery Today, 2020 - Springer
The current treatment strategy for intraductal papillary mucinous neoplasms (IPMNs), based
on the international consensus guideline, has been accepted widely. However, reported …